Compounds > 6-o-stearoyl-n-acetylmuramyl-alanylisoglutamine
Page last updated: 2024-09-03

6-o-stearoyl-n-acetylmuramyl-alanylisoglutamine and Adenocarcinoma

6-o-stearoyl-n-acetylmuramyl-alanylisoglutamine has been researched along with Adenocarcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hersh, EM; Juliano, RL; Lopez-Berestein, G; Mehta, K; Mehta, R1

Other Studies

1 other study(ies) available for 6-o-stearoyl-n-acetylmuramyl-alanylisoglutamine and Adenocarcinoma

ArticleYear
The activation of human monocytes by liposome-encapsulated muramyl dipeptide analogues.
    Journal of immunology (Baltimore, Md. : 1950), 1983, Volume: 130, Issue:4

    Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adenocarcinoma; Breast Neoplasms; Cytotoxicity, Immunologic; Dose-Response Relationship, Immunologic; Humans; Liposomes; Monocytes; Oxygen; Superoxides

1983